[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337425-105":59,"doc-detail-337425-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","bioinformatics-analysis-of-gps1-expression-and-biological-function-in-breast-cancer-journal-paper","Bioinformatics analysis of GPS1 expression and biological function in breast cancer - journal paper","","G protein pathway suppressor 1 (GPS1) participates in the development of many diseases, yet its regulatory mechanism in breast cancer remains unclear. This study combines public-database bioinformatics with in vitro assays to evaluate GPS1 expression, clinical associations, prognosis, and immune relevance. GPS1 is higher in breast tumors than paracancerous tissues, shows diagnostic value (AUC=0.832), and associates with worse survival in Luminal B and low-to-intermediate grade tumors. Functional enrichment links GPS1 to ribonucleoprotein complex formation and Wnt pathway responsiveness; GPS1 knockdown suppresses proliferation, invasion, and migration of MCF7 and MDA-MB-231 cells, highlighting immunotherapy potential via immune microenvironment correlations.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/bioinformatics-analysis-of-gps1-expression-and-biological-function-in-breast-cancer-journal-paper/337425/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/bioinformatics-analysis-of-gps1-expression-and-biological-function-in-breast-cancer-journal-paper/337425.png","ImageObject",300,407,{"name":92,"@type":93},"Himbo","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main objective of this study on GPS1 in breast cancer?","Question",{"text":112,"@type":113},"To determine the biological effects and underlying mechanism of GPS1 in breast cancer by integrating expression/prognostic analysis with experimental assessment of immune relevance and cellular function.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does GPS1 expression differ between breast cancer tissues and paracancerous tissues?",{"text":117,"@type":113},"GPS1 expression is significantly higher in breast cancer tissues than in paracancerous tissues (p \u003C 0.001).",{"name":119,"@type":110,"acceptedAnswer":120},"What are the observed effects of GPS1 knockdown on breast cancer cells?",{"text":121,"@type":113},"GPS1 knockdown inhibits proliferation, invasion, and migration of MCF7 and MDA-MB-231 cells in vitro.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},337425,1790219551,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687197100911,"https://ap-avatar.wpscdn.com/avatar/a000239b6f1da00475?x-image-process=image/resize,m_fixed,w_180,h_180&k=1785132997149421697","Journal of Cancer Research and Clinical Oncology (2024) 150:52  \n[https://doi.org/10.1007/s00432-023-05569-2](https://doi.org/10.1007/s00432-023-05569-2)  \nBioinformatics analysis of GPS1 expression and biological function in breast cancer  \nHong Wei1,2 · Zhaocan Niu1 · Ruixue Ji1 · Wenwen Jiang1 · Jiawei Tang1 · Zhexuan Meng1 · Xiaoyang Cao1 · Xinyi Zhang1 · Xue Liu1,3  \nReceived: 3 August 2023 / Accepted: 20 November 2023 / Published online: 30 January 2024 © The Author(s) 2024  \nAbstract  \nG protein pathway suppressor 1 (GPS1) is involved in the development of many diseases including tumors, but its specific regulatory mechanism in breast cancer is not clear. The goal of the present study was to explore the biological effects and underlying mechanism of GPS1 in breast cancer. Public databases were used to analyze GPS1 expression and the relationship with clinicopathological characteristics and prognosis of breast cancer patients, combined with in vitro experiments to analyze the mechanism of action and immune relevance of GPS1 in breast cancer. Data analysis showed that the expression of GPS1 in breast cancer tissues was significantly higher than that in paracancerous tissues (p \u003C 0.001), and the receiver operating curve (ROC) revealed a higher diagnostic efficiency (AUC = 0.832). Survival analyses indicated that patients with high GPS1 expression made the prognosis worse in Luminal B, low to intermediate-grade breast cancers. Enrichment analysis showed that GPS1 was involved in the formation of ribonucleoprotein complexes, which dynamically altered the fate of RNA; it could also enhance the responsiveness ofthe Wnt pathway by interacting with WBP2 . In addition, GPS1 expression was closely related to the immune microenvironment. GPS1 knockdown inhibits the proliferation, invasion and migration of MCF7 and MDA-MB-231 cells in vitro. This study suggests that the upregulation of GPS1 is associated with the malignant biological behavior and prognosis of breast cancer and may promote cancer progression. The correlation between GPS1 and the immune microenvironment suggests that it may be a potential target for immunotherapy.  \nKeywords GPS1 · Breast cancer · Prognosis · Immune cell infiltration  \nIntroduction  \nBreast cancer is a heterogeneous group of tumors with complex pathogenesis, and rising morbidity and mortality have made it a major global public health problem(Siegel et al. 2023). Despite advances in early diagnosis and clinical interventions that have significantly reduced breast cancer mortality, breast cancer remains an important threat to women's health(Barzaman et al. 2020). Avoiding over-treatment while establishing a set of personalized and precise treatments  \n* Xue Liu [xuelingjing@yeah.net](xuelingjing@yeah.net)  \n1 Jining Medical University, ShanDong, China  \n2 Provincial Key Laboratory of Pathology and Pathophysiology, ShanDong, China  \n3 Jining Key Laboratory of Pharmacology, Jining Medical University, ShanDong, China  \nbased on tumor biomarkers or therapeutic targets is the goal pursued in breast cancer treatment. Therefore, the search for reliable tumor biomarkers or therapeutic targets has become the focus of clinical research in breast cancer.  \nG protein pathway suppressor 1 (GPS1) is an important component of the COP9 signaling complex (CSN), which is involved in a variety of cell growth and developmental processes. The COP9 signalosome is a conserved protein complex consisting of eight subunits, from CSN1 to CSN8 . GPS1 is the largest subunit that constitutes the signalosome, and it is also known as CSN1 (Tsuge et al. 2011 ; Wei and Deng 2003) . GPS1 is involved in the development of many diseases including tumors (Cayli et al. 2012 ; BechOtschir et al. 2001), in vitro experiments revealed that down-regulation of GPS1 expression in ESCC cells significantly inhibited the proliferation, migration and invasion of ESCC cells (Xiong et al. 2023), and gene microarray assay revealed that GPS1 expression was","cbCaig3lav9H7wmL","https://ap.wps.com/l/cbCaig3lav9H7wmL","pdf",7412990,15,"English","# Abstract\n# Introduction\n# Materials and methods\n## Gene expression and prognostic analysis","[{\"question\":\"What is the main objective of this study on GPS1 in breast cancer?\",\"answer\":\"To determine the biological effects and underlying mechanism of GPS1 in breast cancer by integrating expression/prognostic analysis with experimental assessment of immune relevance and cellular function.\"},{\"question\":\"How does GPS1 expression differ between breast cancer tissues and paracancerous tissues?\",\"answer\":\"GPS1 expression is significantly higher in breast cancer tissues than in paracancerous tissues (p \\u003c 0.001).\"},{\"question\":\"What are the observed effects of GPS1 knockdown on breast cancer cells?\",\"answer\":\"GPS1 knockdown inhibits proliferation, invasion, and migration of MCF7 and MDA-MB-231 cells in vitro.\"}]","Bioinformatics analysis of GPS1 expression and biological function in breast cancer - journal paper | PDF",1790019100,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ac2ba71fa2d02ce82a7a00e3f761794c.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/016f5a1458119631994d2444280ffa6f.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/868309f4e72cb5607f1914ad804cccd6.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ac74828cafcef45a47592e4163e21737.webp",980,1301]